BEIJING (Reuters) – Chinese online drug retailer 111.dot Inc. sell Pfizer Inc.’s oral COVID-19 treatment. Paxlobide on Wednesday. This is believed to be the first time Paxlobide has been sold to general consumers in China.
The price is 2,980 yuan ($426.80) per box, according to the 111.dot website. You can buy it on the app if you present a positive result to the new corona test.
According to 111.dot customer service, it sold out an hour and a half after it was published.
It’s unclear how many boxes have been sold, when sales will resume, or whether other retailers will carry the product.
Paxlobide was approved in China in February and is available through hospitals in several provinces for the treatment of high-risk patients.
